Hereditary Testing Market Size, Share, Growth 2023
The Hereditary Testing Market Research Report 2023 offers a thorough examination and insights into the market's size, shares, revenues, various segments, drivers, trends, growth, and development, as well as its limiting factors and local industrial presence. A thorough understanding of the Healthcare sector and its commercial potential is the aim of the market study. The Hereditary Testing Market Report has 100+ pages and has a detailed table of contents, a list of data, tables, and charts, along with an in-depth analysis.
Get a Free Sample Research PDF :
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/107158
Projected market size and growth rate of the Hereditary Testing Market
In December 2021, Helio Health and its commercial partner, Fulgent Genetics, Inc., announced the commercial launch of HelioLiver. This multi-analyte blood test incorporates cell-free DNA methylation patterns and serum protein markers for the early detection of hepatocellular carcinoma (HCC), the most common form of liver cancer. In November 2021, MedGenome Labs, a leading genetic diagnostics and research company, acquired Trident Diagnostics & Healthcare Pvt. Ltd., a diagnostics and radiology healthcare center based in Bengaluru, India. This partnership will help MedGenome make genetic testing accessible to clinicians, patients, and consumers across the country.
Who are the Major Hereditary Testing Market Vendors?
The report will include the profiles of key players such as Illumina, Inc., Genes2Me, Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, CENTOGENE N.V., Thermo Fisher Scientific, Inc., Twist Bioscience, Fulgent Genetics, Inc., MedGenome, and others.
Highlights of the Report:
Fortune Business Insights follows a robust research methodology that involves data triangulation based on top-down, bottom-up approaches, and validation of the estimated market numbers through primary research.
The information used to estimate the market size and forecast for various segments at the global, regional, and country level is derived from the most credible published sources and through interviews with the right stakeholders.
Hereditary Testing Market Growth Drivers :
Hereditary testing is a medical test that detects genetic, chromosomal, or protein alterations, with an aim to confirm or rule out a specific genetic disease, and indicate a person’s risk of developing or passing on a genetic disorder. The main drivers for the hereditary testing market are the steady rise in demand for genetic testing and the rising focus on reproductive genetic health among the population worldwide. An increasing number of genetic screenings of newborns and prenatal is also helping to drive the market's revenue globally. Moreover, an increase in the prevalence of inherited diseases, growing public awareness of the harmful implications of genetic diseases, new breakthroughs in genetic analysis, and the emergence of rare diseases are the key factors driving the hereditary testing market.
For More Information :
https://www.fortunebusinessinsights.com/hereditary-testing-market-107158
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Comments
Post a Comment